2,5-Dioxopyrrolidin-1-yl 2-bromoacetate

Catalog No. :
ACDYLT684
CAS No. :
42014-51-7
Molecular Formula :
C6H6BrNO4
Molecular Weight :
236.02

IUPAC Name:2,5-dioxopyrrolidin-1-yl 2-bromoacetate

2,5-Dioxopyrrolidin-1-yl 2-bromoacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$117.00Login to see priceIn stockInquiry
25g98%$388.00Login to see priceIn stockInquiry
100g98%$1183.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Dioxopyrrolidin-1-yl 2-bromoacetate
IUPAC Name2,5-dioxopyrrolidin-1-yl 2-bromoacetate
MDL No.MFCD00058571
Molecular FormulaC6H6BrNO4
Molecular Weight236.02
SMILESBrCC(=O)ON1C(=O)CCC1=O
InChI KeyNKUZQMZWTZAPSN-UHFFFAOYSA-N
SynonymGS-6096 | S0852 | succinimidyl bromoacetate | SY051341 | SCHEMBL109446 | Bromoacetic acid N-hydroxysuccinimide ester | SBA Cross linker | LCCK0018 | 2,5-Pyrrolidinedione, 1-((bromoacetyl)oxy)- | BAANS | N-Succinimidyl bromoacetate | SBA Crosslinker | SBA
CAS No.42014-51-7
PubChem CID3565210

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDYLT684 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPTFB326 route compound structure diagram
    ACPTFB3261068-52-6 In Stock
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACDYLT684 route product structure diagram
    ACDYLT68442014-51-7 In Stock
Inquiry

2. ACDYLT684 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACDYLT684 route product structure diagram
    ACDYLT68442014-51-7 In Stock
Inquiry

Comments (0)